Related Experiment Videos
[Early developing pancarditis and unclassified inflammatory rheumatism]
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
[Leukemia and pre-leukemic conditions occurring after treatment of breast cancer].
Presse medicale (Paris, France : 1983)·2000
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.
Journal of immunotherapy (Hagerstown, Md. : 1997)·1999
Unusual vascular changes in the red pulp of the spleen accompanying breast carcinoma metastasis.
Pathology, research and practice·1999
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
Leukemia & lymphoma·1998
[Clinical immunomodulatory effects of cannabinoids in autoimmune diseases in internal medicine : A literature review].
La Revue de medecine interne·2026
[Pasteurella multocida septic arthritis in a native joint: Management dilemmas in a penicillin-allergic patient].
La Revue de medecine interne·2026
[Polycythemia associated chronic haemolysis].
La Revue de medecine interne·2026
[Cardiorespiratory functional disorders: A transnosologic approach].
La Revue de medecine interne·2026
[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].
La Revue de medecine interne·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026